Arterial Spin Labelling-Based Blood-Brain Barrier Assessment and Its Applications

키워드

참고문헌 (54)

1. Zeuthen T, "Water-transporting proteins", J Membrane Biol, 234, pp.57~73 (2010)
2. Sweeney MD, "Blood-brain barrier : from physiology to disease and back", Physiol Rev, 99, pp.21~78 (2019)
3. Elahy M, "Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment", Immun Ageing, 12, pp.2~ (2015)
4. Raja R, "MRI measurements of bloodbrain barrier function in dementia: a review of recent studies", Neuropharmacology, 134(Pt B), pp.259~271 (2018)
5. Weiss N, "The blood-brain barrier in brain homeostasis and neurological diseases", Biochim Biophys Acta, 1788, pp.842~857 (2009)
6. Banks WA, "Healthy aging and the blood-brain barrier", Nat Aging, 1, pp.243~254 (2021)
7. Verheggen ICM, "Increase in blood-brain barrier leakage in healthy, older adults", Geroscience, 42, pp.1183~1193 (2020)
8. Leng F, "Neuroinflammation and microglial activation in Alzheimer disease : where do we go from here?", Nat Rev Neurol, 17, pp.157~172 (2021)
9. Rosenberg GA, "Neurological diseases in relation to the bloodbrain barrier", J Cereb Blood Flow Metab, 32, pp.1139~1151 (2012)
10. Montagne A, "Blood-brain barrier permeability and gadolinium : benefits and potential pitfalls in research", JAMA Neurol, 73, pp.13~14 (2016)
11. Starr JM, "Bloodbrain barrier permeability in Alzheimer’s disease : a case-control MRI study", Psychiatry Res, 171, pp.232~241 (2009)
12. Olchowy C, "The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity-A systematic review", PLoS One, 12, pp.e0171704~ (2017)
13. Runge VM, "Critical questions regarding gadolinium deposition in the brain and body after injections of the gadolinium-based contrast agents, safety, and clinical recommendations in consideration of the EMA’s pharmacovigilance and risk assessment committee recommendation for suspension of the marketing authorizations for 4 linear agents", Invest Radiol, 52, pp.317~323 (2017)
14. Harvey HB, "Gadolinium deposition disease : a new risk management threat", J Am Coll Radiol, 17, pp.546~550 (2020)
15. Woolen SA, "Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent : a systematic review and meta-analysis", JAMA Intern Med, 180, pp.223~230 (2020)
16. Detre JA, "Perfusion imaging", Magn Reson Med, 23, pp.37~45 (1992)
17. Kety SS, "The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations", Am J Physiol, 143, pp.53~66 (1945)
18. Eichling JO, "Evidence of the limitations of water as a freely diffusible tracer in brain of the rhesus monkey", Circ Res, 35, pp.358~364 (1974)
19. Paulson OB, "Filtration and diffusion of water across the blood-brain barrier in man", Microvasc Res, 13, pp.113~123 (1977)
20. butanol, "J Cereb Blood Flow Metab", 1987, 527~542
21. Li G, "A model for the blood-brain barrier permeability to water and small solutes", J Biomech, 43, pp.2133~2140 (2010)
22. Wells JA, "Characterizing the origin of the arterial spin labelling signal in MRI using a multiecho acquisition approach", J Cereb Blood Flow Metab, 29, pp.1836~1845 (2009)
23. Ohene Y, "Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling : an aquaporin-4 study", Neuroimage, 188, pp.515~523 (2019)
24. Mahroo A, "Robust multi-TE ASL-based blood-brain barrier integrity measurements", Front Neurosci, 15, pp.719676~ (2021)
25. Wang J, "When perfusion meets diffusion : in vivo measurement of water permeability in human brain", J Cereb Blood Flow Metab, 27, pp.839~849 (2007)
26. Lin Z, "Non-contrast MR imaging of blood-brain barrier permeability to water", Magn Reson Med, 80, pp.1507~1520 (2018)
27. Ze Wang, "Arterial Spin Labeling Perfusion MRI Signal Processing Through Traditional Methods and Machine Learning", Investigative Magnetic Resonance Imaging, 26(4), pp.220~228 (2022), 대한자기공명의과학회
28. St Lawrence KS, "A two-stage approach for measuring vascular water exchange and arterial transit time by diffusion-weighted perfusion MRI", Magn Reson Med, 67, pp.1275~1284 (2012)
29. Parkes LM, "Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling : accounting for capillary water permeability", Magn Reson Med, 48, pp.27~41 (2002)
30. Gregori J, "T2-based arterial spin labeling measurements of blood to tissue water transfer in human brain", J Magn Reson Imaging, 37, pp.332~342 (2013)
31. Lin Z, "Noncontrast assessment of bloodbrain barrier permeability to water: shorter acquisition, testretest reproducibility, and comparison with contrast-based method", Magn Reson Med, 86, pp.143~156 (2021)
32. Silva AC, "Evidence for the exchange of arterial spin-labeled water with tissue water in rat brain from diffusion-sensitized measurements of perfusion", Magn Reson Med, 38, pp.232~237 (1997)
33. St Lawrence KS, "Effect of restricted water exchange on cerebral blood flow values calculated with arterial spin tagging : a theoretical investigation", Magn Reson Med, 44, pp.440~449 (2000)
34. Zhou J, "Twocompartment exchange model for perfusion quantification using arterial spin tagging", J Cereb Blood Flow Metab, 21, pp.440~455 (2001)
35. Wells JA, "Measuring biexponential transverse relaxation of the ASL signal at 9.4 T to estimate arterial oxygen saturation and the time of exchange of labeled blood water into cortical brain tissue", J Cereb Blood Flow Metab, 33, pp.215~224 (2013)
36. Le Bihan D, "MR imaging of intravoxel incoherent motions : application to diffusion and perfusion in neurologic disorders", Radiology, 161, pp.401~407 (1986)
37. Le Bihan D, "Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging", Radiology, 168, pp.497~505 (1988)
38. Le Bihan D, "Magnetic resonance imaging of perfusion", Magn Reson Med, 14, pp.283~292 (1990)
39. Hales PW, "Combined arterial spin labeling and diffusion-weighted imaging for noninvasive estimation of capillary volume fraction and permeability-surface product in the human brain", J Cereb Blood Flow Metab, 33, pp.67~75 (2013)
40. Dai W, "Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging", Magn Reson Med, 67, pp.1252~1265 (2012)
41. Günther M, "Arterial spin labeling in combination with a look-locker sampling strategy : inflow turbo-sampling EPI-FAIR(ITS-FAIR)", Magn Reson Med, 46, pp.974~984 (2001)
42. MacIntosh BJ, "Assessment of arterial arrival times derived from multiple inversion time pulsed arterial spin labeling MRI", Magn Reson Med, 63, pp.641~647 (2010)
43. Mezue M, "Optimization and reliability of multiple postlabeling delay pseudo-continuous arterial spin labeling during rest and stimulus-induced functional task activation", J Cereb Blood Flow Metab, 34, pp.1919~1927 (2014)
44. Shao X, "Mapping water exchange across the blood-brain barrier using 3D diffusion-prepared arterial spin labeled perfusion MRI", Magn Reson Med, 81, pp.3065~3079 (2019)
45. Wang DJ, "Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke-Comparison with dynamic susceptibility contrast enhanced perfusion imaging", Neuroimage Clin, 3, pp.1~7 (2013)
46. Aslan S, "Estimation of labeling efficiency in pseudocontinuous arterial spin labeling", Magn Reson Med, 63, pp.765~771 (2010)
47. Shao X, "Comparison between blood-brain barrier water exchange rate and permeability to gadoliniumbased contrast agent in an elderly cohort", Front Neurosci, 14, pp.571480~ (2020)
48. Fujima N, "Utility of a diffusionweighted arterial spin labeling(DW-ASL)technique for evaluating the progression of brain white matter lesions", Magn Reson Imaging, 69, pp.81~87 (2020)
49. Tiwari YV, "Magnetic resonance imaging of blood-brain barrier permeability in ischemic stroke using diffusion-weighted arterial spin labeling in rats", J Cereb Blood Flow Metab, 37, pp.2706~2715 (2017)
50. Gold BT, "Water exchange rate across the blood-brain barrier is associated with CSF amyloid-β 42 in healthy older adults", Alzheimers Dement, 17, pp.2020~2029 (2021)
51. Olsson B, "CSF and blood biomarkers for the diagnosis of Alzheimer’s disease : a systematic review and meta-analysis", Lancet Neurol, 15, pp.673~684 (2016)
52. Hansson O, "Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment : a follow-up study", Lancet Neurol, 5, pp.228~234 (2006)
53. Shaw LM, "Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects", Ann Neurol, 65, pp.403~413 (2009)
54. Lin Z, "Blood-brain barrier breakdown in relationship to Alzheimer and vascular disease", Ann Neurol, 90, pp.227~238 (2021)

관련 논문AI추천